Skip to Main Content

Paper Details

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy.
Nat Commun
101
2020
ADPGK, Immune-related adverse events, LCP1, PD-L1, anti-PD-1, cancer, irAEs, patient
Author NameAffiliation
Youqiong YeThe University of Texas Health Science Center at Houston McGovern Medical School
Lixia DiaoThe University of Texas MD Anderson Cancer Center
Steven H LinThe University of Texas MD Anderson Cancer Center
Gordon B MillsKnight Cancer Institute, Oregon Health and Science University
Gordon B MillsKnight Cancer Institute, Oregon Health and Science University
  • 1 - 5

Datasets

Release 1.2